Holders

HALOZYME THERAPEUTICS INC

Q1 2025 13F holders

CUSIP
40637HAF6
Type
Debt
Class
NOTE 1.000% 8/1
Total Reported Value ($000, excl. options)
Manager Report date Value ($000) Principal Option type